EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Data-Driven Approaches Used for Compound Library Design for the Treatment of Parkinson’s Disease

Oscar Barrera-Vazquez iD, Jose Alberto Santiago-de-la-Cruz, Nadia Alejandra Rivero-Segura iD, Edgar Antonio Estrella-Parra, Genaro Salvador Morales-Paoli, Edgar Flores-Soto, Juan Carlos Gomez-Verjan iD

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms24021134 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Oscar Barrera-Vazquez und 6 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Farmacología, Facultad de Medicina, Universidad Nacional Autónoma de México, Mexico City 04510, Mexico. Hauptthemen laut MEDLINE: Parkinson Disease, Neurodegenerative Diseases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Consejo Nacional de Ciencia y Tecnología, CONACYT-Paradigmas y Controversias de la Ciencia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Parkinson’s disease (PD) is the second most common neurodegenerative disease in older individuals worldwide. Pharmacological treatment for such a disease consists of drugs such as monoamine oxidase B (MAO-B) inhibitors to increase dopamine concentration in the brain. However, such drugs have adverse reactions that limit their use for extended periods; thus, the design of less toxic and more efficient compounds may be explored. In this context, cheminformatics and computational chemistry have recently contributed to developing new drugs and the search for new therapeutic targets. Therefore, through a data-driven approach, we used cheminformatic tools to find and optimize novel compounds with pharmacological activity against MAO-B for treating PD. First, we retrieved from the literature 3316 original articles published between 2015–2021 that experimentally tested 215 natural compounds against PD. From such compounds, we built a pharmacological network that showed rosmarinic acid, chrysin, naringenin, and cordycepin as the most connected nodes of the network. From such compounds, we performed fingerprinting analysis and developed evolutionary libraries to obtain novel derived structures. We filtered these compounds through a docking test against MAO-B and obtained five derived compounds with higher affinity and lead likeness potential. Then we evaluated its antioxidant and pharmacokinetic potential through a docking analysis (NADPH oxidase and CYP450) and physiologically-based pharmacokinetic (PBPK modeling). Interestingly, only one compound showed dual activity (antioxidant and MAO-B inhibitors) and pharmacokinetic potential to be considered a possible candidate for PD treatment and further experimental analysis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Parkinson DiseaseNeurodegenerative DiseasesHumansAgedMonoamine Oxidase InhibitorsStructure-Activity RelationshipAntioxidantsMonoamine Oxidase

Stichwörter der Autor:innen

Parkinson’s diseasechemoinformaticscomputational drug designdata-driven approach

Substanzen

Monoamine Oxidase InhibitorsAntioxidantsMonoamine Oxidase

Autor:innen und Institutionen

  • Departamento de Farmacología, Facultad de Medicina, Universidad Nacional Autónoma de México, Mexico City 04510, Mexico.
  • Dirección de Investigación, Instituto Nacional de Geriatría (INGER), Mexico City 10200, Mexico.
  • Posgrado de Ciencias Genómicas, Universidad Autónoma de la Ciudad de México, San Lorenzo 290, Colonia Del Valle Sur, Benito Juarez, Mexico City 03100, Mexico.
  • Laboratorio de Fitoquímica, UBIPRO, FES-Iztacala, Universidad Nacional Autónoma de Mexico, Av. De los Barrios No.1, Los Reyes Iztacala, Tlalnepantla 54090, Mexico.
  • Campus en Línea, Universidad Tecnológica de México-UNITEC, Mexico City 09810, Mexico.

ORCID-Profile: Oscar Barrera-Vazquez, Nadia Alejandra Rivero-Segura, Juan Carlos Gomez-Verjan

Förderung

  • Consejo Nacional de Ciencia y Tecnología
  • CONACYT-Paradigmas y Controversias de la Ciencia

Zitieren

APA

Barrera-Vazquez, O., Santiago-de-la-Cruz, J. A., Rivero-Segura, N. A., Estrella-Parra, E. A., Morales-Paoli, G. S., Flores-Soto, E., & Gomez-Verjan, J. C. (2023). Data-Driven Approaches Used for Compound Library Design for the Treatment of Parkinson’s Disease. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24021134

Vancouver

Barrera-Vazquez O, Santiago-de-la-Cruz JA, Rivero-Segura NA, Estrella-Parra EA, Morales-Paoli GS, Flores-Soto E, et al. Data-Driven Approaches Used for Compound Library Design for the Treatment of Parkinson’s Disease. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24021134

BibTeX
@article{BarreraVazquez2023,
  author = {Barrera-Vazquez, Oscar and Santiago-de-la-Cruz, Jose Alberto and Rivero-Segura, Nadia Alejandra and Estrella-Parra, Edgar Antonio and Morales-Paoli, Genaro Salvador and Flores-Soto, Edgar and Gomez-Verjan, Juan Carlos},
  title = {Data-Driven Approaches Used for Compound Library Design for the Treatment of Parkinson’s Disease},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms24021134}
}
Kostenlos starten →